Patrícia Passos Simões, Cristiane Barbosa Chagas, Viviane Monteiro Dias, Juliana Pandini Castelpoggi, Renan Moritz Varnier Rodrigues de Almeida and Rosângela Peluso de Campos Furtado
Background: Metabolic syndrome (MetS) is a complex disorder with a worldwide increasing prevalence. Most patients with Diabetes Mellitus type 2 (DM2) present MetS components such as overweigh/obesity, hypertension, dyslipidemia and hyperinsulinemia. However, population-based data, and more specifically Brazilian data on the subject are scarce, thus creating an interest in characterizing MetS factors in DM2 patients. Therefore, the objective of the present study was to describe the profile of diabetes mellitus type 2 patients (DM2) and to identify the presence of metabolic syndrome in this group.
Methods: Information was collected from the medical records of 127 patients who had a diagnostic of DM2 for at least two year. Biochemical (cholesterol, HDL, LDL, triglycerides, glucose, A1c, urea, creatinine and uric acid) and anthropometrical (weight, height and BMI) parameters and blood pressure were obtained. Patients were classified relatively to the presence of MetS.
Results: Dyslipidemia was present in 42.5% of the patients (n=54). When evaluating the BMI, mean value was 29.7 Kg/m2 (± 5.9). Mean and standard deviation values of fasting glucose were above normal (125.2 ± 45.4 mg/dL), and for LDL 101.6 ± 40,1 mg/dL. In the studied population, the prevalence of MetS was approximately 32%.
Conclusion: Poor glycemic control, hypertension and overweight were highly prevalent in the studied population. Better preventive measures are urgently needed for their control.